In some tumors, PD-L1-expressing myeloid cells (including macrophages) were more abundant than tumor cells expressing PD-L1 [75,76,77], and PD-L1 expression on myeloid cells rather than tumor cells has been suggested to affect the response to a PD-1 blockade [76]. This evidence concerns the gene PDCD1 and neoplasm.